Suresh K. Tipparaju

发表

Indoleamides are active against drug-resistant Mycobacterium tuberculosis

Marco Pieroni, Shichun Lun, Oluseye K. Onajole, 2013, Nature Communications.

Design and Synthesis of Aryl Ether Inhibitors of the Bacillus Anthracis Enoyl‐ACP Reductase

Debbie C. Mulhearn, Michael E. Johnson, A. Mesecar, 2008, ChemMedChem.

Design and synthesis of 2-pyridones as novel inhibitors of the Bacillus anthracis enoyl-ACP reductase.

Debbie C. Mulhearn, Michael E. Johnson, A. Mesecar, 2008, Bioorganic & medicinal chemistry letters.

Targeting EphA2 in Bladder Cancer Using a Novel Antibody-Directed Nanotherapeutic

C. Morrison, M. Mino‐Kenudson, W. Bshara, 2018, Pharmaceutics.

Preliminary structure-activity relationships and biological evaluation of novel antitubercular indolecarboxamide derivatives against drug-susceptible and drug-resistant Mycobacterium tuberculosis strains.

Oluseye K. Onajole, W. Bishai, A. Kozikowski, 2013, Journal of medicinal chemistry.

Formulation optimization of an ephrin A2 targeted immunoliposome encapsulating reversibly modified taxane prodrugs.

W. Kamoun, Z. Huang, D. Drummond, 2019, Journal of controlled release : official journal of the Controlled Release Society.

In pursuit of natural product leads: synthesis and biological evaluation of 2-[3-hydroxy-2-[(3-hydroxypyridine-2-carbonyl)amino]phenyl]benzoxazole-4-carboxylic acid (A-33853) and its analogues: discovery of N-(2-benzoxazol-2-ylphenyl)benzamides as novel antileishmanial chemotypes.

A. Kozikowski, Marco Pieroni, R. Brun, 2008, Journal of medicinal chemistry.

Chelation-control in nucleophilic addition to Cr(CO)3-complexed aryl aldehydes.

V. Puranik, Amitabha Sarkar, Suresh K Tipparaju, 2003, Organic & biomolecular chemistry.

Cleavage of Si-Ar bond vs Si-Me bond: a remarkable counterion effect on reactivity.

V. Puranik, Amitabha Sarkar, Surojit Sur, 2002, Chemical communications.

Identification and development of novel inhibitors of Toxoplasma gondii enoyl reductase.

D. Rice, S. Prigge, C. Roberts, 2010, Journal of medicinal chemistry.

Pyrido[1,2‐a]benzimidazole‐Based Agents Active Against Tuberculosis (TB), Multidrug‐Resistant (MDR) TB and Extensively Drug‐Resistant (XDR) TB

W. Bishai, A. W. Sturm, A. Kozikowski, 2011, ChemMedChem.

Antitumour activity and tolerability of an EphA2-targeted nanotherapeutic in multiple mouse models

W. Kamoun, J. Marks, A. Lugovskoy, 2019, Nature Biomedical Engineering.

Structural analogs of huperzine A improve survival in guinea pigs exposed to soman.

B. P. Doctor, M. Nambiar, A. Kozikowski, 2013, Bioorganic & medicinal chemistry letters.

Antitumour activity and tolerability of an EphA2-targeted nanotherapeutic in multiple mouse models

W. Kamoun, J. Marks, A. Lugovskoy, 2019, Nature Biomedical Engineering.

Abstract 5771: Targeting EphA2 in bladder cancer using a novel antibody-directed nanotherapeutic

C. Morrison, W. Bshara, W. Kamoun, 2018, Experimental and Molecular Therapeutics.